Guangzhou Aimira Innovation Technology Co, Ltd.
ChinaFDA applicant, unverified
- Devices
- 1
What Guangzhou Aimira Innovation Technology Co, Ltd. makes
Guangzhou Aimira Innovation Technology Co., Ltd. manufactures the Superflow Prime Treatment System (ASP-1M), a medical device designed for advanced plasma treatment in healthcare settings.
The Superflow Prime Treatment System (ASP-1M) is classified as a Class II device under FDA regulations and is listed in the FDA’s 510(k) registry. The company is based in the United States.
Catalogue
Superflow Prime Treatment System (ASP-1M) Ref K242286
Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Guangzhou Aimira Innovation Technology Co, Ltd. have in the registry?
The registry currently lists 1 device for Guangzhou Aimira Innovation Technology Co, Ltd.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Guangzhou Aimira Innovation Technology Co, Ltd.'s devices?
Among its 1 most recently registered device, Guangzhou Aimira Innovation Technology Co, Ltd. has devices listed in FDA 510(k) (1 device).
What risk classes do Guangzhou Aimira Innovation Technology Co, Ltd.'s devices fall under?
Among its 1 most recently registered device, the classes recorded for Guangzhou Aimira Innovation Technology Co, Ltd.'s devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Guangzhou Aimira Innovation Technology Co, Ltd. in the registry?
The most recently registered devices listed for Guangzhou Aimira Innovation Technology Co, Ltd. include Superflow Prime Treatment System (ASP-1M).